Inveox GmbH

https://www.inveox.com

LinkedIn: https://www.linkedin.com/company/inveox

inveox GmbH, founded in 2017 in Munich, develops systems to digitize, automate and connect pathology laboratories. The goal is to increase the safety and reliability of cancer diagnoses while simultaneously improving the efficiency and profitability of labs as well as unlocking the potential for personalized diagnostics driven by big data and artificial intelligence. Since its founding, inveox has won numerous awards and been part of several accelerators of renowned companies, such as “Digital Health” (Roche Diagnostics/Plug&Play) and the upcoming Texas Medical Center Accelerator 2019 in Houston, Texas. inveox was voted “Start-up of the Year” by Für-Gründer magazine in the year of its founding and made it on the Forbes list of the “100 most promising startups 2018”. At the end of 2018, inveox opened a subsidiary in Poland (Krakow) and in 2019 became a member of the World Economic Forum. *

	Start	2017-02-23 established
	Group	Inveox (Group)
	Industry	diagnostics (medical/biological)
	Industry 2	laboratory automation equipment
	Person	Sievert, Maria (formerly Driesel) (Inveox GmbH 201702– Managing Director + Co-Founder)
	Person 2	Sievert, Dominik (Inveox GmbH 201702– Managing Director + Co-Founder)

	Region	Garching
	Country	Germany
	Street	8 Lichtenbergstr.
	City	85748 Garching
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Inveox GmbH. (8/5/19). "Press Release: 17 Million for Future Cancer Diagnoses. Inveox Acquires Further Investment". Munich.

		Record changed: 2024-12-29